These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 9311977)

  • 21. Crystal structures of murine angiogenin-2 and -3-probing 'structure--function' relationships amongst angiogenin homologues.
    Iyer S; Holloway DE; Acharya KR
    FEBS J; 2013 Jan; 280(1):302-18. PubMed ID: 23170778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of small-molecule inhibitors of human angiogenin and characterization of their binding interactions guided by computational docking.
    Jenkins JL; Shapiro R
    Biochemistry; 2003 Jun; 42(22):6674-87. PubMed ID: 12779322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective abolition of pancreatic RNase binding to its inhibitor protein.
    Kumar K; Brady M; Shapiro R
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):53-8. PubMed ID: 14681553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
    Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
    J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of phosphate and pyrophosphate ions at the active site of human angiogenin as revealed by X-ray crystallography.
    Leonidas DD; Chavali GB; Jardine AM; Li S; Shapiro R; Acharya KR
    Protein Sci; 2001 Aug; 10(8):1669-76. PubMed ID: 11468363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation of bovine angiogenin using a placental ribonuclease inhibitor binding assay.
    Bond MD; Vallee BL
    Biochemistry; 1988 Aug; 27(17):6282-7. PubMed ID: 3064806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The structure of an engineered domain-swapped ribonuclease dimer and its implications for the evolution of proteins toward oligomerization.
    Canals A; Pous J; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
    Structure; 2001 Oct; 9(10):967-76. PubMed ID: 11591351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic characterization of two active mutants of placental ribonuclease inhibitor that lack internal repeats.
    Lee FS; Vallee BL
    Biochemistry; 1990 Jul; 29(28):6633-8. PubMed ID: 2397204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural features that determine the enzymatic potency and specificity of human angiogenin: threonine-80 and residues 58-70 and 116-123.
    Shapiro R
    Biochemistry; 1998 May; 37(19):6847-56. PubMed ID: 9578571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats.
    Kobe B; Deisenhofer J
    Nature; 1993 Dec 23-30; 366(6457):751-6. PubMed ID: 8264799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the tryptophan residues of human placental ribonuclease inhibitor and its complex with bovine pancreatic ribonuclease A by steady-state and time-resolved emission spectroscopy.
    Sardar PS; Maity SS; Ghosh S; Chatterjee J; Maiti TK; Dasgupta S
    J Phys Chem B; 2006 Oct; 110(42):21349-56. PubMed ID: 17048964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoplasmic ribonuclease inhibitor.
    Shapiro R
    Methods Enzymol; 2001; 341():611-28. PubMed ID: 11582809
    [No Abstract]   [Full Text] [Related]  

  • 34. Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease.
    Acharya KR; Shapiro R; Allen SC; Riordan JF; Vallee BL
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):2915-9. PubMed ID: 8159679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and action of mammalian ribonuclease (angiogenin) inhibitor.
    Lee FS; Vallee BL
    Prog Nucleic Acid Res Mol Biol; 1993; 44():1-30. PubMed ID: 8434120
    [No Abstract]   [Full Text] [Related]  

  • 36. The amino acid sequence of human ribonuclease 4, a highly conserved ribonuclease that cleaves specifically on the 3' side of uridine.
    Zhou HM; Strydom DJ
    Eur J Biochem; 1993 Oct; 217(1):401-10. PubMed ID: 8223579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human angiogenin, an organogenic protein.
    Riordan JF; Vallee BL
    Br J Cancer; 1988 Jun; 57(6):587-90. PubMed ID: 2457389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of human placental ribonuclease inhibitor in Escherichia coli.
    Lee FS; Vallee BL
    Biochem Biophys Res Commun; 1989 Apr; 160(1):115-20. PubMed ID: 2653313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The C-terminal region of human angiogenin has a dual role in enzymatic activity.
    Russo N; Nobile V; Di Donato A; Riordan JF; Vallee BL
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3243-7. PubMed ID: 8622921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis of substrate specificity in porcine RNase 4.
    Liang S; Acharya KR
    FEBS J; 2016 Mar; 283(5):912-28. PubMed ID: 26748441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.